Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Statistical Methods for Analyzing Epidemiological Data

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AI-quantified Myosteatosis at CAC CT for Prediction of Atrial Fibrillation and Heart Failure: The Multi-Ethnic Study of Atherosclerosis.

Radiology. Cardiothoracic imaging·2026

Same author

Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study.

Pharmaceuticals (Basel, Switzerland)·2026

Same author

Benchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation on Screening CT: The LUNA25 Challenge.

Radiology. Artificial intelligence·2026

Same author

Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial.

European radiology·2026

Same author

Young women with (pre)malignant cervical disease in northern Netherlands: what characterises them - A population-based cohort study.

BMC women's health·2026

Same author

Cardiac Radiation Dose and Subclinical Coronary Artery Disease Progression after Breast Cancer Radiotherapy: 2-year Cardiac CT Results from the EARLY-HEART Study.

Radiology. Cardiothoracic imaging·2026

Same journal

Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

Radiology·2026

Same journal

Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

Radiology·2026

Same journal

Erratum for: Blue Rubber Bleb Nevus Syndrome.

Radiology·2026

Same journal

Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

Radiology·2026

Same journal

To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

Radiology·2026

Same journal

The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

Radiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

$Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy$

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European

Noa Antonissen¹, Kiran Vaidhya Venkadesh¹, Renate Dinnessen¹

¹Department of Medical Imaging, Diagnostic Image Analysis Group, Radboud University Medical Center, Route 767, Room 2.30, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.

|September 16, 2025

Summary

This summary is machine-generated.

A deep learning algorithm shows improved lung nodule malignancy prediction in European lung cancer screening trials, significantly reducing false positives for indeterminate nodules compared to the PanCan model.

More Related Videos

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

Related Experiment Videos

Last Updated: Jun 16, 2026

$Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy$

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

Area of Science:

Radiology
Artificial Intelligence
Oncology

Background:

Low-dose CT screening effectively reduces lung cancer mortality.
However, high false-positive rates in screening lead to unnecessary procedures.
Deep learning (DL) offers potential for improved lung nodule risk stratification.

Purpose of the Study:

To externally validate a DL algorithm for estimating lung nodule malignancy risk.
The study utilized pooled data from three major European lung cancer screening trials.
Performance was compared against the established Pan-Canadian Early Detection of Lung Cancer (PanCan) model.

Main Methods:

Retrospective analysis of baseline CT scans from the Danish Lung Cancer Screening Trial, Multicentric Italian Lung Detection trial, and Dutch-Belgian Lung Cancer Screening Trial.
A DL algorithm, trained on US data, was tested on these European cohorts.
Performance metrics, including AUC, were evaluated across the pooled cohort and specific subsets of indeterminate and size-matched nodules.

Main Results:

The DL algorithm demonstrated strong performance across the pooled cohort (AUCs 0.98-0.94), comparable to the PanCan model.
In subset A (indeterminate nodules), DL significantly outperformed PanCan (AUCs 0.95-0.90 vs 0.91-0.86).
DL achieved a 39.4% relative reduction in false-positive findings for indeterminate nodules at 100% sensitivity, and superior AUC in size-matched nodules (0.79 vs 0.60).

Conclusions:

The DL algorithm exhibits superior performance in predicting lung nodule malignancy across diverse European screening datasets.
It significantly reduces false-positive classifications, particularly for indeterminate nodules.
This validates the DL algorithm's potential for enhancing lung cancer screening accuracy and efficiency.